Which has stronger earnings & valuation, ELMD or ECOR?

Electromed has higher revenue and earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Electromed $71.75M 4.29 $5.15M $1.17 31.78 electroCore $32.03M 2.57 -$13.97M -$1.77 N/A

Is ELMD or ECOR more profitable?

Electromed has a net margin of 11.34% compared to electroCore's net margin of -44.08%. Electromed's return on equity of 15.71% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets Electromed 11.34% 15.71% 13.37% electroCore -44.08% -1,956.38% -83.30%

Does the media prefer ELMD or ECOR?

In the previous week, Electromed had 2 more articles in the media than electroCore. MarketBeat recorded 4 mentions for Electromed and 2 mentions for electroCore. electroCore's average media sentiment score of 0.94 beat Electromed's score of 0.13 indicating that electroCore is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Electromed 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral electroCore 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is CARL or ECOR more profitable?

electroCore has a net margin of -44.08% compared to Carlsmed's net margin of -57.76%. Carlsmed's return on equity of -60.74% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets Carlsmed -57.76% -60.74% -29.84% electroCore -44.08% -1,956.38% -83.30%

Is SGHT or ECOR more profitable?

electroCore has a net margin of -44.08% compared to Sight Sciences' net margin of -46.83%. Sight Sciences' return on equity of -52.34% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets Sight Sciences -46.83% -52.34% -28.49% electroCore -44.08% -1,956.38% -83.30%

electroCore (ECOR) Competitors

$9.93 +0.41 (+4.31%)

Closing price 06/10/2026 04:00 PM Eastern

Extended Trading

$9.85 -0.08 (-0.83%)

As of 06/10/2026 08:00 PM Eastern

Compare

ECOR vs. ELMD, CARL, SI, STEX, and SGHT

Should you buy electroCore stock or one of its competitors? MarketBeat compares electroCore with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with electroCore include Electromed (ELMD), Carlsmed (CARL), Shoulder Innovations (SI), Biosig Technologies (STEX), and Sight Sciences (SGHT). These companies are all part of the "medical equipment" industry.

How does electroCore compare to Electromed?

Electromed (NYSE:ELMD) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation.

40.8% of Electromed shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 10.5% of Electromed shares are held by company insiders. Comparatively, 13.8% of electroCore shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Electromed has a beta of 0.53, suggesting that its stock price is 47% less volatile than the broader market. Comparatively, electroCore has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

Electromed has a net margin of 11.34% compared to electroCore's net margin of -44.08%. Electromed's return on equity of 15.71% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
electroCore	-44.08%	-1,956.38%	-83.30%

In the previous week, Electromed had 2 more articles in the media than electroCore. MarketBeat recorded 4 mentions for Electromed and 2 mentions for electroCore. electroCore's average media sentiment score of 0.94 beat Electromed's score of 0.13 indicating that electroCore is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electromed	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
electroCore	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Electromed currently has a consensus target price of $37.50, suggesting a potential upside of 0.86%. electroCore has a consensus target price of $18.00, suggesting a potential upside of 81.27%. Given electroCore's higher possible upside, analysts plainly believe electroCore is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Electromed has higher revenue and earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$71.75M	4.29	$5.15M	$1.17	31.78
electroCore	$32.03M	2.57	-$13.97M	-$1.77	N/A

Summary

Electromed beats electroCore on 13 of the 17 factors compared between the two stocks.

How does electroCore compare to Carlsmed?

Carlsmed (NASDAQ:CARL) and electroCore (NASDAQ:ECOR) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations.

electroCore has a net margin of -44.08% compared to Carlsmed's net margin of -57.76%. Carlsmed's return on equity of -60.74% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.76%	-60.74%	-29.84%
electroCore	-44.08%	-1,956.38%	-83.30%

26.7% of electroCore shares are owned by institutional investors. 13.8% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

electroCore has lower revenue, but higher earnings than Carlsmed. electroCore is trading at a lower price-to-earnings ratio than Carlsmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$50.51M	6.16	-$29.63M	-$2.51	N/A
electroCore	$32.03M	2.57	-$13.97M	-$1.77	N/A

In the previous week, Carlsmed and Carlsmed both had 2 articles in the media. electroCore's average media sentiment score of 0.94 beat Carlsmed's score of 0.29 indicating that electroCore is being referred to more favorably in the news media.

Company	Overall Sentiment
Carlsmed	Neutral
electroCore	Positive

Carlsmed presently has a consensus price target of $19.33, suggesting a potential upside of 68.85%. electroCore has a consensus price target of $18.00, suggesting a potential upside of 81.27%. Given electroCore's higher probable upside, analysts clearly believe electroCore is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Carlsmed and electroCore tied by winning 7 of the 14 factors compared between the two stocks.

How does electroCore compare to Shoulder Innovations?

Shoulder Innovations (NYSE:SI) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

Shoulder Innovations currently has a consensus target price of $21.00, indicating a potential upside of 17.93%. electroCore has a consensus target price of $18.00, indicating a potential upside of 81.27%. Given electroCore's higher probable upside, analysts clearly believe electroCore is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

electroCore has a net margin of -44.08% compared to Shoulder Innovations' net margin of -81.78%. Shoulder Innovations' return on equity of -35.11% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-81.78%	-35.11%	-20.58%
electroCore	-44.08%	-1,956.38%	-83.30%

26.7% of electroCore shares are held by institutional investors. 29.0% of Shoulder Innovations shares are held by company insiders. Comparatively, 13.8% of electroCore shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

electroCore has lower revenue, but higher earnings than Shoulder Innovations. electroCore is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$53.89M	6.85	-$40.36M	-$166.96	N/A
electroCore	$32.03M	2.57	-$13.97M	-$1.77	N/A

In the previous week, electroCore had 2 more articles in the media than Shoulder Innovations. MarketBeat recorded 2 mentions for electroCore and 0 mentions for Shoulder Innovations. electroCore's average media sentiment score of 0.94 beat Shoulder Innovations' score of 0.50 indicating that electroCore is being referred to more favorably in the news media.

Company	Overall Sentiment
Shoulder Innovations	Positive
electroCore	Positive

Summary

Shoulder Innovations beats electroCore on 8 of the 15 factors compared between the two stocks.

How does electroCore compare to Biosig Technologies?

Biosig Technologies (NASDAQ:STEX) and electroCore (NASDAQ:ECOR) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

7.2% of Biosig Technologies shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 52.7% of Biosig Technologies shares are owned by insiders. Comparatively, 13.8% of electroCore shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Biosig Technologies has a beta of 1.85, suggesting that its stock price is 85% more volatile than the broader market. Comparatively, electroCore has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

Biosig Technologies currently has a consensus price target of $8.00, indicating a potential upside of 768.24%. electroCore has a consensus price target of $18.00, indicating a potential upside of 81.27%. Given Biosig Technologies' higher probable upside, equities analysts clearly believe Biosig Technologies is more favorable than electroCore.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biosig Technologies	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Biosig Technologies has a net margin of 0.00% compared to electroCore's net margin of -44.08%. Biosig Technologies' return on equity of -717.92% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biosig Technologies	N/A	-717.92%	-336.75%
electroCore	-44.08%	-1,956.38%	-83.30%

electroCore has higher revenue and earnings than Biosig Technologies. electroCore is trading at a lower price-to-earnings ratio than Biosig Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biosig Technologies	$40K	4,187.76	-$462.77M	-$9.71	N/A
electroCore	$32.03M	2.57	-$13.97M	-$1.77	N/A

In the previous week, electroCore had 1 more articles in the media than Biosig Technologies. MarketBeat recorded 2 mentions for electroCore and 1 mentions for Biosig Technologies. Biosig Technologies' average media sentiment score of 1.88 beat electroCore's score of 0.94 indicating that Biosig Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Biosig Technologies	Very Positive
electroCore	Positive

Summary

Biosig Technologies beats electroCore on 8 of the 14 factors compared between the two stocks.

How does electroCore compare to Sight Sciences?

Sight Sciences (NASDAQ:SGHT) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

electroCore has a net margin of -44.08% compared to Sight Sciences' net margin of -46.83%. Sight Sciences' return on equity of -52.34% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sight Sciences	-46.83%	-52.34%	-28.49%
electroCore	-44.08%	-1,956.38%	-83.30%

Sight Sciences has a beta of 2.41, meaning that its share price is 141% more volatile than the broader market. Comparatively, electroCore has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market.

In the previous week, electroCore had 1 more articles in the media than Sight Sciences. MarketBeat recorded 2 mentions for electroCore and 1 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 1.87 beat electroCore's score of 0.94 indicating that Sight Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
Sight Sciences	Very Positive
electroCore	Positive

electroCore has lower revenue, but higher earnings than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sight Sciences	$77.36M	3.39	-$38.43M	-$0.71	N/A
electroCore	$32.03M	2.57	-$13.97M	-$1.77	N/A

Sight Sciences currently has a consensus target price of $8.14, suggesting a potential upside of 68.96%. electroCore has a consensus target price of $18.00, suggesting a potential upside of 81.27%. Given electroCore's higher possible upside, analysts plainly believe electroCore is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sight Sciences	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

55.5% of Sight Sciences shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 30.9% of Sight Sciences shares are held by company insiders. Comparatively, 13.8% of electroCore shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Sight Sciences beats electroCore on 11 of the 16 factors compared between the two stocks.

Get electroCore News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ECOR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ECOR vs. The Competition

Export

Metric	electroCore	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$78.97M	$2.96B	$6.50B	$11.95B
Dividend Yield	N/A	1.70%	2.67%	5.61%
P/E Ratio	-5.61	17.80	24.41	23.63
Price / Sales	2.57	289.01	502.24	103.14
Price / Cash	N/A	56.16	43.05	54.72
Price / Book	-47.29	3.88	10.43	6.70
Net Income	-$13.97M	$75.85M	$3.56B	$337.26M
7 Day Performance	-0.10%	-3.90%	-2.94%	-2.43%
1 Month Performance	50.23%	-5.48%	-0.39%	0.19%
1 Year Performance	75.44%	14.98%	20.10%	23.15%

electroCore Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ECOR electroCore	3.4708 of 5 stars	$9.93 +4.3%	$18.00 +81.3%	+72.7%	$78.97M	$32.03M	N/A	50
ELMD Electromed	0.9252 of 5 stars	$36.72 +0.3%	$37.50 +2.1%	+86.6%	$304.08M	$71.75M	48.97	160	Positive News Insider Trade
CARL Carlsmed	3.2243 of 5 stars	$10.17 -8.4%	$19.33 +90.1%	N/A	$301.75M	$50.51M	N/A	100	Positive News Short Interest Increase
SI Shoulder Innovations	3.8366 of 5 stars	$13.92 -1.8%	$21.00 +50.9%	N/A	$294.07M	$47.32M	N/A	61
STEX Biosig Technologies	2.8358 of 5 stars	$1.19 -13.5%	$8.00 +575.1%	N/A	$249.07M	$40K	N/A	50	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ECOR) was last updated on 6/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

electroCore (ECOR) Competitors

ECOR vs. ELMD, CARL, SI, STEX, and SGHT

How does electroCore compare to Electromed?

Summary

How does electroCore compare to Carlsmed?

Summary

How does electroCore compare to Shoulder Innovations?

Summary

How does electroCore compare to Biosig Technologies?

Summary

How does electroCore compare to Sight Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ECOR vs. The Competition

electroCore Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

electroCore (ECOR) Competitors

ECOR vs. ELMD, CARL, SI, STEX, and SGHT

How does electroCore compare to Electromed?

Do institutionals and insiders hold more shares of ELMD or ECOR?

Which has more volatility and risk, ELMD or ECOR?

Is ELMD or ECOR more profitable?

Does the media prefer ELMD or ECOR?

Do analysts recommend ELMD or ECOR?

Which has stronger earnings & valuation, ELMD or ECOR?

Summary

How does electroCore compare to Carlsmed?

Is CARL or ECOR more profitable?

Do institutionals and insiders hold more shares of CARL or ECOR?

Which has better valuation & earnings, CARL or ECOR?

Does the media prefer CARL or ECOR?

Do analysts prefer CARL or ECOR?

Summary

How does electroCore compare to Shoulder Innovations?

Do analysts rate SI or ECOR?

Is SI or ECOR more profitable?

Do institutionals & insiders have more ownership in SI or ECOR?

Which has preferable valuation and earnings, SI or ECOR?

Does the media favor SI or ECOR?

Summary

How does electroCore compare to Biosig Technologies?

Do institutionals and insiders believe in STEX or ECOR?

Which has more risk & volatility, STEX or ECOR?

Do analysts recommend STEX or ECOR?

Is STEX or ECOR more profitable?

Which has preferable earnings & valuation, STEX or ECOR?

Does the media refer more to STEX or ECOR?

Summary

How does electroCore compare to Sight Sciences?

Is SGHT or ECOR more profitable?

Which has more risk & volatility, SGHT or ECOR?

Does the media prefer SGHT or ECOR?

Which has better valuation & earnings, SGHT or ECOR?

Do analysts recommend SGHT or ECOR?

Do institutionals and insiders hold more shares of SGHT or ECOR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ECOR vs. The Competition

electroCore Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools